A multicenter, randomized, double-blind placebo-controlled, single dose trial of the safety and efficacy of intravenous ibuprofen for treatment of pain in pediatric patients undergoing tonsillectomy

Jonathan R. Moss; Mehernoor F. Watcha; Laima P. Bendel; Denise L. McCarthy; Stacy L. Witham; Chris D. Glover

doi:10.1111/pan.12381

A multicenter, randomized, double-blind placebo-controlled, single dose trial of the safety and efficacy of intravenous ibuprofen for treatment of pain in pediatric patients undergoing tonsillectomy

Pediatric Anesthesia ◽

10.1111/pan.12381 ◽

2014 ◽

Vol 24 (5) ◽

pp. 483-489 ◽

Cited By ~ 40

Author(s):

Jonathan R. Moss ◽

Mehernoor F. Watcha ◽

Laima P. Bendel ◽

Denise L. McCarthy ◽

Stacy L. Witham ◽

...

Keyword(s):

Single Dose ◽

Pediatric Patients ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Dose Trial ◽

Intravenous Ibuprofen

Download Full-text

Phase 2, randomized, double‐blind, placebo‐controlled, 4‐week study to evaluate the safety and efficacy of OPA‐ 15406 (difamilast), a new topical selective phosphodiesterase type‐4 inhibitor, in Japanese pediatric patients aged 2–14 years with atopic dermatitis

The Journal of Dermatology ◽

10.1111/1346-8138.15137 ◽

2019 ◽

Vol 47 (1) ◽

pp. 17-24 ◽

Cited By ~ 2

Author(s):

Hidehisa Saeki ◽

Naoko Baba ◽

Kazuhide Oshiden ◽

Yuji Abe ◽

Hidetsugu Tsubouchi

Keyword(s):

Atopic Dermatitis ◽

Pediatric Patients ◽

Phase 2 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Phosphodiesterase Type

Download Full-text

A phase II, multicenter, randomized, double-blind, placebo-controlled trial of the safety and efficacy of velafermin (CG53135-05) administered intravenously as a single dose for the prevention of oral mucositis in patients receiving autologous hematopoietic stem cell transplant (AHSCT)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2005.11.068 ◽

2006 ◽

Vol 12 (2) ◽

pp. 21-22 ◽

Cited By ~ 1

Author(s):

E. Anaissie ◽

M.W. Schuster ◽

D. Hurd ◽

W. Bensinger ◽

J. Mason ◽

...

Keyword(s):

Stem Cell ◽

Single Dose ◽

Hematopoietic Stem Cell Transplant ◽

Stem Cell Transplant ◽

Controlled Trial ◽

Cell Transplant ◽

Double Blind ◽

Hematopoietic Stem ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

A double-blind, placebo-controlled single dose trial of intravenous flumazenil in Alzheimer's disease

Human Psychopharmacology Clinical and Experimental ◽

10.1002/(sici)1099-1077(199906)14:4<239::aid-hup94>3.0.co;2-r ◽

1999 ◽

Vol 14 (4) ◽

pp. 239-245 ◽

Cited By ~ 6

Author(s):

Lisa Templeton ◽

Andrew Barker ◽

Keith Wesnes ◽

David Wilkinson

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Single Dose ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Trial

Download Full-text

Longer analgesic effect with naproxen sodium than ibuprofen in post-surgical dental pain: a randomized, double-blind, placebo-controlled, single-dose trial

Current Medical Research and Opinion ◽

10.1080/03007995.2019.1655257 ◽

2019 ◽

Vol 35 (12) ◽

pp. 2149-2158 ◽

Cited By ~ 1

Author(s):

Stephen A. Cooper ◽

Paul Desjardins ◽

Patrick Brain ◽

Alberto Paredes-Diaz ◽

Emanuel Troullos ◽

...

Keyword(s):

Single Dose ◽

Analgesic Effect ◽

Naproxen Sodium ◽

Dental Pain ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Trial

Download Full-text

The Effect of Single-Dose Preemptive Intravenous Ibuprofen on the Intraoperative Hemodynamic Parameters, Recovery Characteristics, and Acute Pain after Laparoscopic Cholecystectomy: A Randomized Double-Blind, Placebo-Controlled Clinical Trial

International Journal of Anesthetics and Anesthesiology ◽

10.23937/2377-4630/1410118 ◽

2020 ◽

Vol 7 (4) ◽

Author(s):

Sezen Ozlem ◽

Cevik Banu ◽

Saracoglu Kemal Tolga

Keyword(s):

Clinical Trial ◽

Laparoscopic Cholecystectomy ◽

Single Dose ◽

Acute Pain ◽

Controlled Clinical Trial ◽

Hemodynamic Parameters ◽

Double Blind ◽

Double Blind Placebo ◽

Intravenous Ibuprofen

Download Full-text

Relapse Prevention in Pediatric Patients With ADHD Treated With Atom-oxetine: A Randomized, Double-Blind, Placebo-Controlled Study

Yearbook of Pediatrics ◽

10.1016/s0084-3954(07)70073-8 ◽

2006 ◽

Vol 2006 ◽

pp. 92-93

Author(s):

J.A. Stockman

Keyword(s):

Relapse Prevention ◽

Pediatric Patients ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1160853.622273 ◽

2009 ◽

Author(s):

Davide Pareyson ◽

Chiara Marchesi

Keyword(s):

Ascorbic Acid ◽

Disease Type ◽

Efficacy Trial ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Charcot Marie Tooth ◽

Charcot Marie Tooth Disease ◽

Tooth Disease

Download Full-text

Faculty Opinions recommendation of A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1162202.622674 ◽

2009 ◽

Author(s):

Michael O'Connor

Keyword(s):

Acute Respiratory Distress Syndrome ◽

Acute Lung Injury ◽

Lung Injury ◽

Active Site ◽

Distress Syndrome ◽

Recombinant Factor Viia ◽

Factor Viia ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1164186.624873 ◽

2009 ◽

Author(s):

Ladislav Senolt

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Jak Inhibitor ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

Safety and Efficacy of Monoclonal Antibody VIS410 in Adults with Uncomplicated Influenza A Infection: Results from a Randomised, Double-Blind, Placebo-Controlled Study

SSRN Electronic Journal ◽

10.2139/ssrn.3271424 ◽

2018 ◽

Author(s):

Ellie Hershberger ◽

Susan Sloan ◽

Kristin Narayan ◽

Catherine A. Hay ◽

Patrick Smith ◽

...

Keyword(s):

Monoclonal Antibody ◽

Influenza A ◽

Controlled Study ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text